Clinical Trials Directory

Trials / Sponsors / LENZ Therapeutics, Inc

LENZ Therapeutics, Inc

Academic / Other · 8 registered clinical trials.

StatusTrialPhaseStarted
CompletedPlasma Pharmacokinetics and Safety of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With Pr
Eye Diseases, Presbyopia, Refractive Errors
Phase 12023-07-06
CompletedPhase 3 Efficacy Study of LNZ100 & LNZ101 for the Treatment of Presbyopia
Presbyopia, Near Vision, Refractive Error
Phase 32023-03-06
CompletedPhase 3 Safety Study for the Treatment of Presbyopia Subjects
Presbyopia, Near Vision, Miosis
Phase 32023-02-21
CompletedPhase 3 Evaluation of the Safety and Efficacy of LNZ100 & LNZ101 for the Treatment of Presbyopia
Presbyopia, Refractive Error, Eye Diseases
Phase 32022-12-19
CompletedEvaluation of the Safety and Effectiveness of Aceclidine (LNZ101) and Aceclidine + Brimonidine (LNZ100) in the
Presbyopia, Refractive Errors, Eye Diseases
Phase 22022-08-06
CompletedEvaluation of the Safety and Effectiveness of Aceclidine/Brimonidine (LNZ101) and Aceclidine (LNZ100) in the T
Presbyopia, Refractive Errors, Eye Diseases
Phase 22022-05-05
CompletedA Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to M
Presbyopia
Phase 22017-04-30
CompletedEvaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia
Presbyopia
Phase 22015-09-01